Related references
Note: Only part of the references are listed.Gene methylation in gastric cancer
Yiping Qu et al.
CLINICA CHIMICA ACTA (2013)
Capecitabine in the treatment of esophageal and gastric cancers
Elizabeta C. Popa et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer
Koji Otani et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2013)
Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer
Sae-Won Han et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, methylight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients
Veronique Quillien et al.
CANCER (2012)
RB-Pathway Disruption Is Associated with Improved Response to Neoadjuvant Chemotherapy in Breast Cancer
Agnieszka K. Witkiewicz et al.
CLINICAL CANCER RESEARCH (2012)
Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer
Yoshimi Arima et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer
Qi-Ming Yu et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Clinical Potential of DNA Methylation in Gastric Cancer: A Meta-Analysis
Nur Sabrina Sapari et al.
PLOS ONE (2012)
Methylation Subtypes and Large-Scale Epigenetic Alterations in Gastric Cancer
Hermioni Zouridis et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Management of advanced gastric cancer
Timothy J. Price et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel
Jing Gao et al.
BMC CANCER (2011)
CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients
S. R. Park et al.
BRITISH JOURNAL OF CANCER (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Aberrant Gene Methylation in the Lymph Nodes Provides a Possible Marker for Diagnosing Micrometastasis in Gastric Cancer
Masatsugu Hiraki et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Promoter Methylation of Specific Genes is Associated with the Phenotype and Progression of Colorectal Adenocarcinomas
Jin C. Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer
Sun-Young Kong et al.
PHARMACOGENOMICS (2009)
Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?
Carmelo Pozzo et al.
ONCOLOGIST (2008)
Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients
Mayumi Mitsuno et al.
JOURNAL OF GASTROENTEROLOGY (2007)
Methylation of tumor-related genes in neoadjuvant-treated gastric cancer:: Relation to therapy response and clinicopathologic and molecular features
Rudolf Napieralski et al.
CLINICAL CANCER RESEARCH (2007)
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
Daniel J. Weisenberger et al.
NATURE GENETICS (2006)
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies
S. Ogino et al.
GUT (2006)
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis
Shuji Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients
H Fukuda et al.
CANCER INVESTIGATION (2006)
Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer
F Graziano et al.
CLINICAL CANCER RESEARCH (2004)
The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5′-deoxy-5-fluorouridine
T Nishina et al.
EUROPEAN JOURNAL OF CANCER (2004)
Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines
CN Arnold et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Share Paper
